Cardiff Lexington to Report Second Quarter 2026 Financial Results and Host Conference Call on Wednesday, August 12, 2026

Rhea-AI Summary

Cardiff Lexington (OTCQX:CDIX) will release its financial and operating results for the second quarter ended June 30, 2026, on Wednesday, August 12, 2026, before hosting an investor conference call at 11:00 a.m. ET.

U.S. participants can join by dialing (888) 506-0062, while international participants should dial (973) 528-0011 and use access code 876877. The call and slide deck will be webcast at https://www.webcaster5.com/Webcast/Page/3131/54266, with an online archive available afterward. A telephone replay will be accessible until August 26, 2026 at (877) 481-4010 (U.S.) or (919) 882-2331 (international), using access code 54266. Cardiff Lexington describes itself as a healthcare services holding company focused on orthopedic, spine, and pain management platforms, pursuing scalable growth through acquisitions and strategic partnerships.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LEXINGTON, KY / ACCESS Newswire / August 6, 2026 / Cardiff Lexington Corporation (OTCQX:CDIX) a publicly traded healthcare services holding company focused on orthopedic, spine, and pain management platforms, today announced that the Company will host an investor conference call to discuss its financial and operating results for the second quarter ended June 30, 2026, on Wednesday, August 12, 2026, at 11:00 am ET.

The Company will release its financial and operating results for the second quarter ended June 30, 2026, prior to the call on Wednesday, August 12, 2026.

Shareholders and interested parties may participate in the conference call by dialing (888) 506-0062 and international participants should dial (973) 528-0011 and use access code: 876877. The call and the accompanying slide deck will also be webcast at:

https://www.webcaster5.com/Webcast/Page/3131/54266

An online archive of the webcast will be available at the above webcast link. A replay of the conference call will be available one hour after completion of the call until Wednesday, August 26, 2026, by dialing (877) 481-4010 and international participants should dial (919) 882-2331. All callers must use access code 54266 to access the replay.

About Cardiff Lexington Corporation:

Cardiff Lexington Corporation is a publicly traded healthcare services holding company focused on building a regional and national platform in orthopedic, spine, and pain management markets. Through its operating subsidiaries, including Nova Ortho and Spine, the Company delivers a comprehensive suite of services including diagnostics, interventional pain management, surgical coordination, and specialty care.

The Company's strategy is centered on disciplined capital deployment, operational efficiency, and scalable growth through acquisitions and strategic partnerships within highly fragmented healthcare markets.

FORWARD LOOKING STATEMENT: This news release contains forward looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. These risks include the failure to meet schedule or performance requirements of the Company's business, the Company's liquidity position, the Company's ability to obtain new business, the emergence of competitors with greater financial resources, and the impact of competitive pricing. In the light of these uncertainties the forward-looking events referred to in this release might not occur.

Cardiff Lexington Investor Relations
investorrelations@cardifflexington.com
(800) 628-2100 ext. 705

or

IMS Investor Relations
cardifflexington@imsinvestorrelations.com
(203) 972-9200

SOURCE: Cardiff Lexington Corporation

View the original press release on ACCESS Newswire

FAQ

When will Cardiff Lexington (OTCQX:CDIX) report its Q2 2026 financial results?

Cardiff Lexington plans to release its Q2 2026 financial and operating results on Wednesday, August 12, 2026. According to the company, the figures will be issued prior to its investor conference call scheduled that same day at 11:00 a.m. Eastern Time.

What time is the Cardiff Lexington (CDIX) Q2 2026 earnings conference call on August 12, 2026?

The Cardiff Lexington Q2 2026 investor conference call is scheduled for 11:00 a.m. ET on August 12, 2026. According to the company, the call will discuss financial and operating results for the quarter ended June 30, 2026.

How can investors access the Cardiff Lexington (CDIX) Q2 2026 earnings call by phone?

Investors can join the Cardiff Lexington Q2 2026 call by dialing (888) 506-0062 in the U.S. or (973) 528-0011 internationally. According to the company, participants must use access code 876877 to enter the live conference.

Is there a webcast for the Cardiff Lexington (CDIX) Q2 2026 earnings call?

Yes. Cardiff Lexington will webcast its Q2 2026 conference call and slide deck at https://www.webcaster5.com/Webcast/Page/3131/54266. According to the company, an online archive of the webcast will be available at the same link after the event.

How can I listen to the replay of Cardiff Lexington’s Q2 2026 conference call?

A replay will be available from one hour after the call until August 26, 2026 by dialing (877) 481-4010 (U.S.) or (919) 882-2331 (international). According to Cardiff Lexington, callers must enter access code 54266.

What does Cardiff Lexington (CDIX) describe as its core healthcare business focus?

Cardiff Lexington describes itself as a healthcare services holding company focused on orthopedic, spine, and pain management platforms. According to the company, its subsidiaries provide diagnostics, interventional pain management, surgical coordination, and specialty care within fragmented healthcare markets.